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Abstract
Background: Preliminary clinical studies on the single-implant mandibular overdenture (SIMO) have reported
favorable results as an alternative to the conventional complete dentures for rehabilitation of the edentulous
mandible. Clinical and patient-reported outcomes were assessed but no evidence is available with respect to
the cost-effectiveness of this treatment, which is particularly important to test whether the incremental cost
associated with the implant treatment is justified facing the benefits from the intervention. Thus, the aim of
this study is to assess the cost-effectiveness of single-implant mandibular overdentures.
Methods/design: This randomized clinical trial will include edentulous individuals who meet eligibility criteria.
Participants will be randomized into one of the treatment groups: a conventional complete denture group or
a single-implant mandibular overdenture group. Direct costs related to therapies in both groups will be identified,
measured and valuated for 1 year after treatment. Oral health-related quality of life and satisfaction with the
dentures will be the primary outcome variables. Incremental cost-effectiveness ratios will be estimated and
graphically presented on cost-effectiveness planes. A Markov decision tree will be constructed to set out the
consequences of the competing alternatives. Sensitivity analysis on the most important assumptions will be
performed in order to assess the robustness of the model.
Discussion: This is the first trial-based cost-effectiveness study on single-implant mandibular overdentures.
Specific challenges in designing the protocol are considered. The expected results are of high clinical
relevance and may contribute to the decision-making process when choosing between different alternatives
for the rehabilitation of the edentulous mandible.
Trial registration: ClinicalTrials.gov Identifier: NCT02710357, registered on 11 March 2016.
Keywords: Cost-effectiveness, Economic evaluation, Dental economics, Overdentures, Complete dentures,
Patient satisfaction
* Correspondence: claudio_leles@ufg.br
1School of Dentistry, Federal University of Goiás, Avenida Universitária
Esquina com 1ª Avenida, s/n. Setor Universitário, Goiânia, Goiás CEP
74605-220, Brazil
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Nogueira et al. Trials  (2016) 17:533 
DOI 10.1186/s13063-016-1646-0
Background
Tooth loss is an important public health problem that
affects different population groups, having a greater
incidence in older people within disadvantaged communi-
ties [1, 2]. In Brazil, 53.7 % of the 65–74 year-old group do
not have any teeth according to a national survey held in
2010 [3] and the conventional tissue-supported complete
denture is still the most common clinical treatment.
Although most edentulous patients appear to benefit from
complete dentures and report satisfactory oral comfort
and masticatory function, it is fairly frequent to find
patients who are poorly adapted to their dentures, even
with dentures that are perceived to be prosthodontically
acceptable [4]. Individuals who experience difficulties with
their dentures usually complain of pain, discomfort, poor
oral coordination and limited functioning, mainly caused
by low retention and stability and an unfavorable condi-
tion of the supporting tissues associated with the man-
dibular denture.
Proper management of unstable and uncomfortable
dentures is very challenging, even for experienced pros-
thodontists. In most cases, the use of dental implants to
retain a mandibular denture is recommended to assure
a more favorable prognosis for those difficult-to-treat
edentulous patients. The mandibular overdenture,
retained by two implants in the interforaminal region,
has been the standard of care for the edentulous
mandible [5, 6]. Available evidence shows that it leads
to better outcomes compared to the conventional denture,
such as increased patient satisfaction and oral health-
related quality of life (OHRQoL) [7]. However, there is no
reliable evidence on the ideal number of implants needed
to retain a mandibular overdenture [8], and the reduction
of the number of implants to a single implant for denture
retention has been proposed as a less invasive and
less costly alternative compared to other overdenture
designs [9].
The single-implant mandibular overdenture (SIMO)
was originally recommended for older edentulous
patients experiencing discomfort and functional difficul-
ties with conventional mandibular dentures [10]. The
implant is placed in the symphyseal region where favor-
able bone quality and quantity is usually found. This
ensures satisfactory primary stability and high implant
success rates, even for immediately loaded implants [11].
In addition, this less invasive and less costly implant
intervention might allow more people to benefit from
this treatment, even with general health concerns.
Previous clinical studies have shown that SIMO sig-
nificantly improves patient satisfaction and improves
OHRQoL impacts when compared to a conventional
mandibular denture [12, 13]. Favorable results regarding
several other relevant outcomes, such as higher implant
survival rates, minimal marginal bone loss and acceptable
incidence of adjustments and repairs, were also re-
ported [9–18].
From an economic perspective, the available evidence
strongly supports the view that mandibular overdentures
retained by two or four implants are cost-effective when
financers are willing to pay in excess of the calculated
cost-effectiveness acceptance thresholds, considering
that willingness to pay may vary considerably between
financers pay within and between health care systems
and outcome measures [19, 20]. The availability of
simpler interventions, like SIMO, could increase the
demand for implant overdentures by reducing the
potential risks of surgical interventions and the incre-
mental costs associated with the treatment in compa-
rison to overdenture designs with greater number of
implants.
The aim of this study is to assess the cost-effectiveness
of the SIMO. The study hypothesis is that SIMO is more
effective but more costly than the conventional denture,
though this incremental cost is relatively low for the
offered effectiveness in terms of clinical and patient-
reported outcomes.
Methods/design
This study is a randomized clinical trial. Study groups
will include patients who are receiving a complete maxil-
lary denture as opposed to either a conventional man-
dibular denture (CD – control group) or a SIMO (SIMO
– experimental group). Although the two-implant man-
dibular overdenture is established as the standard of
care for the edentulous mandible [5, 6], in most parts
of the world the CD is still considered the most common
treatment for edentulous patients. Therefore, we chose
the CD as the reference strategy to SIMO to test the
incremental effect of placing a single implant in the
symphyseal region for denture retention.
A flowchart of the study is detailed in Fig. 1. The
final study protocol was approved by the Research
Ethics Committee of the Federal University of Goiás in
September 2014 (protocol number: 020/2012). Two docu-
ments related to the reporting of clinical trials and health
economic evaluations were used to guide the structure of
this protocol: the Consolidated Standards of Reporting
Trials (CONSORT Statement) [21] and the Consolidated
Health Economic Evaluation Reporting Standards
(CHEERS) [22] (see Additional file 1). All clinical proce-
dures will be performed at the School of Dentistry of the
Federal University of Goiás, Goiânia, Goiás, Brazil. Partici-
pants will not be charged for any treatment costs.
Participants
Target population and sample
The target population will comprise fully edentulous
subjects. The eligible participants will receive maxillary
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and mandibular conventional complete dentures. The pri-
mary list of participants will be retrieved from the data-
base of registered patients in the local public health
system. For the initial screening, no restrictions regarding
gender and age will be considered. Treatment needs will
be based on normative criteria and/or on subject’s
expressed need for replacement of old dentures.
Inclusion and exclusion criteria
Referred subjects will be evaluated by means of a thor-
ough clinical assessment and a panoramic radiograph.
For inclusion in the study, the screened potential partici-
pants must have no contraindications for implant sur-
gery (mainly related to uncontrolled systemic diseases)
and present enough bone volume in the mandibular
midline area for an implant length of at least 8 mm
without the need for bone augmentation procedures.
They should be able to understand and answer the ques-
tionnaires used in the study and agree to participate by
providing a written informed consent.
Noncompliant participants will be excluded from the
study. Moreover, individuals who do not agree to be
randomly allocated to the treatment study group (CD or
SIMO) will be excluded. Subjects who present signs of
untreated temporomandibular disorders or uncontrolled
systemic or oral conditions that require additional treat-
ments will be referred for proper treatment and be
excluded from the study.
Stopping criteria
A participant will be removed from the trial in case of
withdrawal of the consent or discontinuation of the
prescribed treatment program (deviate from protocol);
for example, if the participant decides to have other
implant treatment modalities during the follow-up
period (such as overdentures with different number of
implants and/or fixed implant dentures). Any condition
preventing the attendance to follow-up visits will be
considered as a participant dropout, such as incapacity
due to advanced physical debilitation or moving to
another city. Interrupted follow-up due to withdraw
and/or dropout will be documented and consent will be
sought from participants to retain data collected up to
the point of withdrawal/dropout.
Sample size estimation
In this study, sample size was estimated for each of the
two treatment groups considering a minimum power of
0.80 (type II error rate) at a two-sided 0.05 significance
level (type I error rate). A previous single-group clinical
trial that assessed the incremental effect of the SIMO
treatment compared to the CD, and considered the
outcome satisfaction with the dentures and OHRQoL,
served as the data source for this sample size estimation
[23]. A minimum of 24 patients will enter this two-
treatment parallel-design study, considering that the true
difference between treatments is 7.4 units for OHIP-
Fig. 1 Flowchart of the study
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EDENT and 2.6 units for satisfaction scores, assuming
unequal variances for both groups. An increase of 10 %
to reduce the impact of loss to follow-up on study power
resulted in a minimum final sample of 28 participants,
14 in each treatment group.
Randomization
A computer-based random number generator will be
used to assign participants into the treatment groups
[24]. In order to prevent imbalance between groups,
participants will be stratified according to gender [25].
Block randomization will be used to randomly assign
participants to sets of different sizes, using unsorted
numbers with a range from 1 to 2 (representing the two
treatments) and an allocation ratio of 1:1 for the control
and experimental groups. The sequence will be concealed
in opaque, consecutively numbered envelopes for each
block. After each enrollment, the next randomization
envelope will be opened, according to the previously
established sequence. An independent collaborator will
manage the allocation and inform participants about
their assigned groups.
If a participant allocated to the SIMO group refuses to
receive the implant treatment (noncompliance), follow-
up will occur the same way as in the control group.
Moreover, intention-to-treat analysis will be performed,
which means that during statistical analysis noncompli-
ant participants will be kept in their original group, even
if they did not receive the allocated treatment. This may
provide a more conservative estimation of treatment
effect, minimizing the probability of type I error occur-
rence [26].
Masking/blinding
To avoid selection bias and ensure adequate allocation
concealment, their treatment group will only be revealed
for each participant after the assessment of the baseline
outcomes, which will occur after the delivery and regular
use of the new set of conventional dentures. Since full
blinding for the two interventions is not possible for
those involved with treatment management and collec-
tion of data, only those collecting and analyzing clinical
data from masticatory performance tests will be unaware
of the assigned treatment.
Interventions
Control group (complete denture treatment)
New maxillary and mandibular dentures will be fabri-
cated following a standardized protocol. Clinical steps
will include: (1) anamnesis and preliminary impression
with alginate (Jeltrate Dustless, Dentsply, Brazil) using
stock trays, (2) final impression with a custom tray and
zinc oxide eugenol impression material (Lysanda, Lysanda
Produtos Odontológicos Ltda., São Paulo, Brazil), (3)
occlusal registrations and mounting in a semiadjustable
articulator fixed in average settings, without the use of a
facebow, (4) a try-in visit to assess the artificial teeth
(Trilux, Dental Vip Ltda, Pirassununga, São Paulo,
Brazil), (5) delivery of the dentures and (6) visits for
adjustment. All laboratory procedures will be carried
out by the same dental technician using standard pro-
cedures for complete denture processing.
Moreover, the dentures will be technically evaluated
by an experienced prosthodontist in order to guarantee
maximum quality according to each case. When needed,
retreatment or any adjustment/repair in the dentures
will be performed accordingly. Participants will receive
regular maintenance for their dentures, including adjust-
ments for elimination of sore areas, denture relining and
repair of fractures, when needed, until the end of the
follow-up period.
Experimental group (single-implant mandibular overdenture
(SIMO))
Prosthodontic phase All prosthodontic procedures for
construction of conventional maxillary and mandibular
dentures will be performed similarly to the control
group.
Presurgical procedures After insertion and adjustment
of the new dentures, implant placement surgery will be
planned with the aid of panoramic and lateral cepha-
lometric radiographs, which will serve to determine
implant dimensions and position, as well as to assess the
conditions of the implant bone site. A cephalometric
radiograph will be acquired with the dentures in situ
and, to make the proposed implant position evident, a
thin strip of lead foil will be fixed outlining the outer
surface of the lower denture in the midline position [11].
Imaging exams should confirm the presence of sufficient
bone volume for the placement of an implant with a
length of at least 8 mm.
In order to assess general health conditions, blood
tests will be required, including complete blood count,
prothrombin time, activated partial thromboplastin time
and fasting blood glucose. In cases of abnormal findings,
the participant will be referred to the physician in order
to treat the condition before having the implant inser-
tion surgery done.
Surgical and prosthodontic procedures Antibiotic
prophylaxis with 2 g of amoxicillin will be administered
1 h preoperatively [27]. In case of allergy to penicillin,
600 mg of clindamycin will be used. Each patient will
then receive a Straumann® Standard Plus SLActive®
regular neck implant (Straumann 0.33.051S/052S/053S,
Institute Straumann AG, Basel, Switzerland) in the
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mandibular midline. The implant length will be defined
according to the bone height availability, which will be
assessed by means of the panoramic and cephalometric
radiographs, with the aid of a transparent template. After
infiltration anesthesia, incision will be performed using a
size 15C disposable scalpel blade. Surgical access will be
as conservative as possible, involving a minimal crestal
incision, except when a more extensive access is needed
for regularization of the alveolar bone crest at the discre-
tion of the surgeon. Drilling sequence and implant inser-
tion will be executed according to the manufacturer’s
protocol. The upper denture will serve as a reference
guide for the installation of the implant and it will be
properly disinfected before surgery with 2 % chlor-
hexidine digluconate by being soaked in this solution
for 10 min [28].
Bone quality and jaw shape will be noted according to
the classification proposed by Lekholm and Zarb [29].
Furthermore, final insertion torque will be recorded
from the drilling unit with the aid of a manual torque
wrench. Implant stability quotient (ISQ) will be assessed
using a magnetic resonance frequency device (Osstell
Mentor, Integration Diagnostics, Göteborg, Sweden).
Final insertion torque will be kept around 20 N.cm and
the implant platform placed at least 1 mm above the
gingival margin. A healing abutment will be connected
and the implant will be allowed to heal for 3 weeks.
Sutures will be performed with simple interrupted
stitches and removed after 7 days. In addition, the
mandibular denture will be relined with a soft acrylic
temporary relining material (Soft Comfort, Dencril, São
Paulo, Brazil).
Postoperatively, participants will be advised to have a
soft food diet and to rinse with a 0.12 % chlorhexidine
mouthwash for 1 week. Additionally, paracetamol
750 mg will be provided as the analgesic option to be
taken to a maximum of four times daily as needed, since
it has been shown to be effective in relieving postope-
rative pain and has a low incidence of adverse effects
[30]. Additional postoperative medication will be pre-
scribed for case-specific situations.
After 3 weeks, the healing abutment will be removed,
the gingival collar will be irrigated with 0.12 % chlor-
hexidine and implant stability will be assessed. Subse-
quently, a 3.4-mm retentive titanium anchor abutment
(Straumann 048.439, Institute Straumann AG, Basel,
Switzerland) will be connected and tightened to
35 N.cm with a torque wrench. The temporary relining
material will be removed and a space relief will be
made in the inner part of the denture to accommo-
date the abutment and the corresponding elliptical matrix
(Straumann 048.456, Institute Straumann AG, Basel,
Switzerland). The matrix will be incorporated to the
denture using self-curing acrylic resin and the patient will
be instructed to keep the upper and lower dentures firmly
occluded in the habitual position until the final
polymerization of the resin. Occlusion will be checked
and, if necessary, adjustments will be made to guaran-
tee a balanced occlusal scheme. No interventions will
be performed to the maxillary denture.
Outcomes
The effectiveness of both treatments will be measured
by means of two primary patient-centered outcomes:
oral health-related quality of life (OHRQoL) impacts and
satisfaction with the dentures:
– OHRQoL impacts: the cross-culturally adapted
Brazilian version of the Oral Health Impact Profile
for edentulous subjects (OHIP-EDENT) will be
used [31, 32]. It contains 19 items divided into
four different subscale domains: (I) masticatory
discomfort and disability (four items), (II)
psychological discomfort and disability (five items),
(III) social disability (five items) and (IV) oral
pain and discomfort (five items). The items are
answerable on a 3-point Likert scale and responses
will be summed to obtain an overall OHIP-EDENT
score and for each of the four domains. Higher
scores represent worse OHRQoL
– Satisfaction with the dentures: a 10-cm
uninterrupted Visual Analog Scale will be used
in order to assess the participants’ ratings of their
satisfaction with the upper and lower dentures in
relation to the parameters “general satisfaction,”
“comfort,” “stability,” “aesthetics,” “ability to speak,”
and “ability to chew.” Each participant will indicate
their level of satisfaction with each parameter by
marking a point along the scale, in which one end
signifies “unsatisfied” and the other end signifies
“satisfied,” respectively. Then, an assistant will
convert each mark into a value of between 0 to
100 by placing a transparent template with
numbered intervals from 0 to 100 mm.
Masticatory performance will be assessed as a second-
ary outcome using a two-colored chewing gum test and
a qualitative and quantitative colorimetric method to
measure the color-mixing ability [33]. The selected test
food will be the Vivident Fruitswing “Karpuz/Asai
Üzümü” (Perfetti van Melle, Turkey), a two-colored gum
comprising a green and a dark violet layer measuring
43 mm × 12 mm × 3 mm. Participants will be asked to
sit upright in a dental chair and to chew the gum on
their preferred chewing side for 20 and 50 cycles. The
chewed gum will be then retrieved from the oral cavity,
placed in a transparent plastic bag and flattened to a
1-mm thick wafer by pressing on a custom-made
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polyvinyl chloride plate with a milled depression of 1 mm
× 50 mm × 50 mm. Each specimen will be labeled with
random numbers to allow blind assessment. Both sides of
the specimen will be scanned using a flatbed scanner at a
resolution of 500 dpi. Visual and electronic analysis of
the chewed gum samples will be done according to
the classification proposed by Schimmel et al. [33]. Ana-
lysis will be made by two investigators blinded to the study
groups and treatment stage. ViewGum software (dHAL
Software, Kifissia, Greece, www.dhal.com) will be used for
electronic colorimetric analysis.
Other clinical outcomes will be recorded in order to
provide a comprehensive assessment of the intervention,
such as implant survival rate, implant stability quotient,
peri-implant bone changes, peri-implant soft tissue
aspects and incidence of prosthodontic repair/adjust-
ment events. Control variables, such as age and gender,
as well as baseline clinical variables will be recorded for
patient description and subgroup data analysis. Subjects
will also be classified according to the American College
of Prosthodontists’ Index [34].
Table 1 shows all the study outcomes and the time
frame for assessment throughout the clinical trial.
Economic analysis
Study perspective
A cost-effectiveness analysis will be performed from the
health care provider perspective. Cost estimations of the
study interventions will be derived from the clinical trial,
which is a reproduction of a typical private setting for
oral health care in Brazil, since implant treatment is not
covered by the public health system and has limited
reimbursement from insurance companies. An additional
analysis will be performed using the patient perspective, in
which costs will be estimated according to the reference
pricing of dental procedures and treatments by the
Brazilian Dental Association (Classificação Brasileira
Hierarquizada de Procedimentos Odontológicos –
CBHPO) and reference gross costs will be derived from a
panel of specialists.
Time horizon and discount rates
The time frame for primary data collection will be 1 year
starting from group assignment of each participant of
the clinical trial. For modeling-based data, a maximum
time horizon of 10 years will be assumed as a relevant
time frame for clinical trials, both to accommodate the
needs of decision-makers and to provide a “trajectory” of
summary measures over time [35]. In this case, both
costs and outcomes will be discounted at an annual rate
of 5 %, as recommended by Brazilian guidelines [36].
Estimation of costs
Cost estimation will include all expenditures and re-
sources associated with the alternative interventions
during the 1-year follow-up period. Relevant costs will
Table 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) diagram
Study period
Enrollment Allocation Post allocation






Conventional denture (control group) x x x x
Single-implant mandibular overdenture (SIMO)
(intervention group)
x x x x x x
Assessments:
Oral health-related quality of life (OHRQoL) x x x
Satisfaction with dentures x x x
Masticatory performance x x x
Implant stabilitya x x x
Peri-implant bone levela x x x
Peri-implant soft tissue healtha x x x
Prosthodontic events
Costs
aAssessed only for the single-implant mandibular overdenture (SIMO) group
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be grouped into dental costs (items used for treatment)
and nondental costs (e.g., transportation fares). Some as-
sumptions were made for the inclusion and valuing of
relevant resource items: (1) no capital costs will be
considered, (2) societal costs related to broader costs to
society (e.g., productivity losses resulting from treat-
ment, family costs, dietary adaptation, etc.) will not be
included.
Cost estimation will involve three stages: identification
of relevant resource items used for treatment associated
with the provision of the interventions; estimation of the
amount of resources used (in natural units); and applica-
tion of prices (unit costs) to each of the resource items.
Table 2 details the parameters that will be used in cost
analysis, according to the treatment groups.
Overall costs for the two alternative treatments will
include the summative value of all direct costs listed in
Table 2. The currency used for cost estimations will be
Brazilian reals – BRL R$. Price date will be recorded and
values will be adjusted to the year of the registered costs
by applying specific price indexes. If currency conversion
is required for the final report, purchasing power parity
(PPP) will be used to equalize the purchasing power of
different currencies by eliminating the differences in
price levels between countries. Alternatively, a widely
used currency, such as the US dollar, will be adopted for
cost estimations.
Data analysis
Descriptive and inferential statistics
Data will be checked and cleaned blind to the treatment
group allocation and analysis will be carried out accor-
ding to the intention-to-treat principle. Statistical ana-
lysis will comprise between-group comparisons of the
effectiveness outcomes (OHIP and patient satisfaction)
and will be performed using independent t tests or non-
parametric tests in case of asymmetric distribution of
Table 2 Description of items included in cost analysis, quantification, sources and references for item valuing for the two alternative
treatments









Denture fabrication (Monthly wage/monthly working time)
× time spent
Time in min Reference salary Yes Yes
Implant surgery time (Monthly wage/monthly working time)
× time spent
Time in min Reference salary No Yes
Overdenture time (Monthly wage/monthly working time)
× time spent
Time in min Reference salary No Yes
Follow-up (Monthly wage/monthly working time)
× time spent
Time in min Reference salary Yes Yes
Implant Units × price per unit Microcosting Price catalog No Yes
Prosthodontic components Units × price per unit Microcosting Price catalog No Yes
Medication Units × price per unit Microcosting Reference price No Yes
Imaging exams Units × price per unit Gross-costing Mean market prices Yes Yes
Surgical consumables Overall consumable resources/cases Microcosting Mean market prices No Yes
Prosthodontic laboratory Units × price per unit Gross-costing Reference prices Yes Yes
Blood tests Overall cost of exams per patient Gross-costing Reference prices No Yes
Consumables
Infection control and PPE Overall consumable resources/cases Microcosting Mean market prices Yes Yes
Dental materials Overall consumable resources/cases Microcosting Mean market prices Yes Yes
Instruments/equipments
Conventional denture Estimation of lifespan for each item Estimated annual costs Panel of specialists Yes Yes
Implant/overdenture Estimation of lifespan for each item Estimated annual costs Panel of specialists No Yes
Nondental direct costs
Transportation fares Number of visits per patient Self-reported Cost from public transportation Yes Yes
CD conventional mandibular denture, PPE personal protective equipment, SIMO single-implant mandibular overdenture
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data (IBM-SPSS 23.0 software; IBM Corp, 2015). An
alpha level of 0.05 will be set for significance.
Cost-effectiveness analysis
A cost-effectiveness analysis will be carried out by calcu-
lating the incremental cost-effectiveness ratio (ICER),
which represents a single, common effect that measures
the difference in magnitude between the two alternatives
using data retrieved from a clinical trial, expressed in
terms of the incremental cost per unit of effect, as
follows:
ICER ¼ ðCosta−CostbÞ=ðEf f ectivenessa−Ef f ectivenessbÞ;
where the measures of effectiveness will be considered
to be the satisfaction with the dentures and the OHR-
QoL impacts.
Decision analysis will be carried out to model the
outcomes of decision between the two alternatives. This
analysis considers that the outcomes of decisions are not
certain, but that the probabilities of different outcomes
are known from the trial-based data. The Markov model
with Monte Carlo simulation will be used since the
decision analysis problem involves risk that is continu-
ous over time, the timing of events is important, and
important events may happen more than once.
Markov models assume that a patient is always in
one of a finite number of discrete health states, called
Markov states [37]. All events are represented as transi-
tions from one state to another. Important events for this
study will be represented in a tree-type diagram that iden-
tifies the decision alternatives (decision node), the list of
the possible outcomes of each alternative (chance nodes)
and the sequence of events (terminal node). The full
decision tree will contain all the relevant nodes and the
paths between them, as well as the probabilities assigned
to chance events and the values attached to each potential
final state. Data derived from the clinical trial will be used
to construct a Markov decision-tree model of CD versus
SIMO, considering the most relevant clinical events, their
related probabilities of transitions from one state to
another) and estimated costs from each course of action.
One-way sensitivity analysis will be performed to
assess the impact that changes in certain parameters
(e.g., implant/component costs, time horizon, etc.) will
have on the model’s conclusions, as well as to determine
which parameters are the key drivers of a model’s
results. A tornado diagram will be constructed to show
graphically the results of various assumptions on the
final outcome in the sensitivity analysis. TreeAge Pro
2014 software will be used for the cost-effectiveness
analysis.
Discussion
This is the first trial-based cost-effectiveness study on
SIMOs. Specific challenges in designing the protocol are
considered. The expected results are of high clinical
relevance and may contribute to the clinical decision-
making process, offering a novel approach for the treat-
ment of mandibular edentulism.
The scarcity of economic analysis in prosthodontics
has major practical implications, since clinical decision-
making might occur without there being reliable evidence
relating to the costs and consequences of prosthodontic
care. Therefore, the best possible decision cannot
always be achieved in the scenario of limited financial
resources [38]. Another critical challenge to conduct
cost-effectiveness analysis in prosthodontics is to in-
corporate validated clinical outcomes that can be used
to compare and contrast costs of the intervention
[38]. This study protocol suggests two commonly used
patient-reported measures for edentulous subjects: a
validated instrument for assessment of OHRQoL
impacts and a multi-item measure of patient satisfac-
tion with the mandibular denture. The definition of
resource items, criteria for cost calculation and
sources for item valuing are also proposed.
The incorporation of implants as part of oral rehabi-
litation alternatives also gives rise to important issues
regarding health economics. Since many implant inter-
ventions involve relevant costs for both the patient and
prosthodontist, the search for a more efficient use of
available resources to achieve better benefits with lower
costs is mandatory in many clinical situations. A system-
atic literature review [39] on economic aspects of
implant interventions, focusing on cost-effectiveness of
dental implants compared with other conventional treat-
ment options, showed that replacement of multiple teeth
with dental implants was associated with higher initial
costs along with greater improvements in patient-
reported outcomes. However, there is an evident lack of
studies dealing with measurement of costs and conse-
quences in specific clinical scenarios involving edentu-
lous subjects and implants. This is both surprising and
disappointing because this type of study is essential due
to concern about the increase in health care expenditure
associated with limited resources to meet the demands
of both patients and society [40].
Finally, from an economic perspective, it is important
to bear in mind that, in most societies, dental care is not
fully incorporated as an integral part of general health
services. Hence, there is a predominance of private
dental care based on the fee-for-service payment system,
in which dentists are paid for every service that they
provide based on the usual and customary fees charged
in the local area. This probably explains why there is
scarce evidence derived from economic studies in
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dentistry [41, 42] and reinforces the need for economic
evaluations of dental interventions, in order to improve
decision-making processes and contribute to the deve-
lopment of health care policies.
Trial status
The trial started recruitment in March 2016.
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